Scientific Publications: 1999

  1. Luanne T; Albert J; Liitsola Q; Green SD; Carr JK; Leitner T; McCutchan FE; Salminen MO. Virtually Full-Length Sequences of HIV Type 1 Subtype J Reference Stains. AIDS Res Hum Retro. 1999;15(3):293-297.
  2. Cox JH; Garner RP; Redfield RR; Aronson NE; Davis C; Ruiz N; Birx DL. Antibody-Dependent Cellular Cytotoxicity in HIV Type 1-Infected Patients Receiving VaxSyn, a Recombinant gp160 Envelope Vaccine. AIDS Res Hum Retro. 1999;15(9):847-854.
  3. Report from a UNAIDS/WHO/NIID Meeting. Tokyo, October 28-30 1998. AIDS Vaccine in Asia: Needs and Opportunities. AIDS. 1999;13:UNAIDS1-UNAIDS13.
  4. Carr JK; Laukkanen T; Salminen MO; Albert J; Alaeus A; Kim B; Sanders-Buell E; Birx DL; McCutchan FE. Characterization of Subtype A HIV-1 from Africa by Full Genome Sequencing. AIDS. 1999;13:1819-1826.
  5. Lewis MG; Yalley-Ogunro J; Greenhouse JJ; Brennan TP; Bo Jiang J; VanCott TC; Lu Y; Eddy GA; Birx DL. Limited Protection from a Pathogenic Chimeric Simian-Human Immunodeficiency Virus Challenge Following Immunization with Attenuated Simian Immunodeficiency Virus. J Virol. 1999; 73(2):1262-1270.
  6. Beyrer C; Artenstein AW; Rugpao S; Stephens H; VanCott TC; Robb ML; Rinkaew M; Birx DL; Khamboorruang C; Zimmerman PA; Nelson KE; Natpratan C. Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently seronegative Female Sex Workers in Northern Thailand. J Infec Dis. 1999; 179:59-67.
  7. Sitz KV; Ratto-Kim S; Hodgkins AS; Robb ML; Birx DL. Proliferative Responses to Human Immunodeficiency Virus Type 1 (HIV-1) gp120 Peptides in HIV-1-Infected Individuals Immunized with HIV-1 rgp120 or rgp160 Compared with Nonimmunized Uninfected Controls. J Infect Dis. 1999; 179:817-24.
  8. Sei S; Sandelli SL; Theofan G; Ratto-Kim S; Kumagai M; Loomis-Price LD; Cox JH; Jarosinki P; Walsek CM; Pim Brouwers, Venzon DJ; Xu J; Pizzo PA; Moss RB; Robb ML; Wood LV. Preliminary Evaluation of Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen in Children with HIV-1 Infection. J Infect Dis. 1999; 180:626-40.
  9. Ratto-Kim S Sitz KV; Garner RP; Kim JH; Davis C; Aronson N; Ruiz N; Tencer K; Redfield RR; Birx DL. Repeated Immunization with Recombinant gp160 Human Immunodeficiency Virus (HIV) Envelope Protein in Earle HIV-1 Infection: Evaluation of the T Cell Response. J Infect Dis. 1999; 179:337-344.
  10. ChanbancherdP; Brown AE; Trichavaroj R; Tienamporn P; Puthakird P; Limpairojn N; VanCott TC; De Souza MS. Application of Dried Blood Spot Specimens for Serologic Subtyping of Human Immunodeficiency Virus Type 1 in Thailand. J Clin Microbiol. 1999; 37(3):804-806.
  11. Mascola JR; Lewis MG; Stiegler G; Harris D; VanCott TC; Hayes D; Louder MK; Brown CR; Sapan CV; Frankel SS; Lu Y; Robb ML; Katinger H; Birx DL. Protection of Macaques Against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies. J Virol. 1999; 73(5):4009-4018.
  12. Zolla-Pazner S; Gorny MK; Nyambi PN; VanCott TC; Nadas A. Immunotyping of Human Immunodeficiency Virus Type 1 (HIV): An Approach to Immunologic Classification of HIV. J Virol. 1999; 73(5):4042-4051.
  13. Neilson JR; John GC; Carr JK; Lewis P; Kreiss JK; Jackson S; Nduati RW; Mbori-Ngacha D; Panteleeff DD; Bodrug S; Giachetti C; Bott MA; Richardson BA; Bwayo J; Ndinya-chola J; Overbaugh J. Subtypes of Human Immunodeficiency Virus type 1 and Disease Stage Among Women in Nairobi, Kenya. J Virol. 1999; 73(5):4393-4403.
  14. VanCott TC; Mascola JR; Loomis-Price LD; Sinangil F; Zitomersky N; McNeil J; Robb ML; Birx DL; Barnett S. Cross-Subtype Neutralizing Antibodies Induced in Baboons by a Subtype E gp120 Immunogen Based on an R5 Primary Human Immunodeficiency Virus Type 1 Envelope. J Virol. 1999; 73(6):3640-4650.
  15. Vahey M; Nau M; Barrick S; Cooley JD; Sawyer R; Sleeker AA; Vickerman P; Bloor S; Larder B; Michael NL; Wegner SA. Performance of the Affimatrix GeneChip HIV PRT 440 Platform for Antiretroviral Drug Resistance Genotyping of Human Immunodeficiency Virus Type 1 Cladesand Viral Isolates With Length Polymorphisms. J Clin Microbiol. 1999; 37(8):2533-2537.
  16. Michael NL; Herman SA; Kwok S; Dreyer K; Wang J; Christopherson C; Spadoro JP; Young KKY; Polonis V; McCutchan FE; Carr J; Mascola J; Jagodzinski LL; Robb ML. Development of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 and Performance of an Improved AMPLICOR HIV-1 MONITOR Test with Isolates of Diverse Subtypes. J Cin Microbiol. 1999; 37(8):2557-2563.
  17. Gonzalez E; Bamshad M; Sato, Mummidi S; Dhanda R; Catano G; Cabrera S; McBride M; Cao X; Merrill G; O’connell P; Bowden DW; Freedman BL; Anderson SA; Walter EA; Evans JS; Stephan KT; Clark RA; Tyagi S; Ahuja SS; Dolan MJ; Ahuja SK. Race-Specific HIV-1 Disease-modifying effects associated with CCR5 Haplotypes. Proc Natl Acad Sci. 1999; 96(21):12004-12009.
  18. Brodine SK; Shaffer RA; Starky MJ; Tasker SA; Gilcrest JL; Louder MK; Barile A; VanCott TC; Vahey MT; McCutchan FE; Birx DL; Richman DD; Mascola JR. Drug Resistance Patterns, Genetic Subtypes, Clinical Features, and Risk Factors in Military Personnel with HIV-1 Seroconversion. Ann Intern Med. 1999; 131:502-506.
  19. McCutchan FE; Carr JK; Bajani M; Sanders-Buell E; Harry TO; Stoekli TC; Robbins KE; Gashau W; Nasidi A; Jessens W Kalish ML. Subtype G and Multiple Forms of A/G Intersubtype Recombinant Human Immunodeficiency Virus Type 1 in Nigeria. Virol. 1999; 254:226-234.
  20. Sambor AM; Pombo de Oliveira MS; Fahardi A; Carr JK; Carvalho MF; Blattner WA; Kim JH. Human T-Lymphotropic Virus Type 1 tax Polymorphisms in a Transmission Cohort: No Association Between Sequence Variation and Disease Manifestations. J Hum Virol. 1999, 2(5):308-314.
  21. Michael NL; Moore JP. HIV-1 Entry Inhibittors: Evading the Issue. Nat Med. 1999; 5(7):740-742.
  22. Michael NL. Host Genetic Influences on HIV-1 Pathogenesis. Curr Opin Immunol. 1999; 11:466-474.
  23. Mariani R;Wong S; Mulder LF; Wilkinson DA; Reinhart AL; LaRosa G; Nibbs R; O'Brien TR; Michael NL; Connor RI; Macdonald M; Busch M; Koup RA; Landau NR. CCR2-64I Polymorphism Is Not Associated with Altered CCR5 Expression or Coreceptor Funtion. J Virol. 1999; 73:2450-2459.
  24. Sullivan PS; Schable C; Koch W; Do AN; Spira T; Lansky A; Ellenberger D; Lal RB; Hyer C; Davis R; Marx M; Paul S; Kent J; Armor R; McFarland J; Lafontain J; Mottice S; Cassol SA; Michael N; Seronegative AIDS Clinical Study Group. Persistantly Negative HIV-1 Antibody Enzyme Immunoassay Screening Reults for Patients With HIV-1 Infection and AIDS: Serological, Clinical, and Virologic Results. AIDS. 1999; 13;89-96.
  25. Katial RK; Ratto-Kim S; Sitz KV; Moriarty R; Engler RJM. Varicella Immunity: Persistant Serologic Non-response to Immunization. Ann Allergy Asthma Immunol. 1999; 82:431-434.
  26. Salmon-Ceron D; Excler JL. Safety and Immunogenicity of a Live Recombinant Canarypox Virus Expressing HIV Type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) Followed by a p24E-V3 MN Synthetic Peptide (CTLB-36) Administered in Healthy Volunteers at Low Risk for HIV Infection. AIDS Res Hum Retroviruses. 1999; 15(7):633-645.
  27. Evans TG; Keefer MC; Weinhold KJ; Wolff M; Montefiori D; Dorse GJ; Graham BS; McElrath MJ; Clement-Mann ML; Mulligan MJ; Fast P; Walker MC; Excler JL; Duliege AM; Tartaglia J; NIAID AIDS Vaccine Evaluation Group. A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responnses in Seronegative Volunteers. J Infect Dis. 1999; 180:290-8
  28. Raux M; Finkielsztein L; Salmon-Ceron D; Bouchez H; Excler JL; Dulioust E; Grouin JM;Sicard D; Blondeau C. Comparison of the Distribution of IgG and IgA Antibodies in Serum and Various Mucosal Fluids of HIV Type 2-Infected Subjects. AIDS Res Hum Retroviruses. 1999; 15(15):1365-1376.
  29. Markowitz M; Vesanen M; Tenner- Racz K; Cao Y; Binley JM; Talal A; Hurley A; Ji X; Chaudrey MR; Yaman M; Frankel S; Health-Chiozzi M; Leonard JM; Moore JP; Racz P; Nixon DF; Ho DD. The Effect of Commencing Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Immune Responses. J Infect Dis. 1999: 525-37.
  30. McCutchan FE. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. In: Kuiken C; Foley B; Hahn B; Marx P; McCutchan F; Mellors JW; Mullins J; Wolinsky S; Korber B eds. Human Retroviruses and AIDS. Los Alamos; New Mexico, 1999.
  31. McCutchan FE. Global Diversity HIV-1. In: Crandall K. The Evolution of HIV. Baltimore; Maryland: The Johns Hopkins University Press, 1999: pp41-101.
  32. Girard MP; Excler JL. Human Immunodeficiency Virus. In: Plotkin SA; Orenstein WA eds. Vaccines 3rd ed. Philadelphia; London: WB Saunders Company, 1999: Chapter 38:928-967.
  33. Lane JR. Isolation and Expansion of HIV from Cells and Body Fluids by Coculture. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 1:3-10.
  34. Lane JR. Quantitative HIV Culture. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 2:11-16.
  35. Lane JR. Quantitation of Cell-Free HIV by Reverse Transcriptase Activity. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 3:17-22.
  36. Louder MK; Mascola JR. Determination of Syncytium-Inducing Phenotype of Primary HIV-1 Isolates Using MT-2 Cells. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 4:23-29.
  37. Louder MK; Mascola JR. Determination of HIV-1 Chemokine Coreceptor Tropism Using Transduced Human Osteosarcoma (HOS) Cells. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 5:29-35.
  38. Gilliam BL. Methods of Culturing HIV-1 From Semen. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 8:51-60.
  39. McDonald RA. Detection of HIV-1 Nucleic Acids by Southern Blotting. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 9:61-70.
  40. McDonald RA; Smith CAD. Detection of HIV-1 Nucleic Acids by Northern Blotting. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 10:71-83.
  41. Vahey M; Barrick SC; Nau M. Quantitation of HIV-1 gag DNA and RNA From Single Frozen Cell Pellets. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 13:99-118.
  42. Gilliam BL. Quantitations of HIV-1 RNA in Genital Secretions. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 17:151-164.
  43. Tse L; Michael NL. Determination of the Promoter Activity of HIV-1 Using the Chloramphenicol Acetyltransferase Reporter Gene Assay. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 19:185-196.
  44. Riley JL; Carroll RG. Quantitation of HIV-1 Entry Cofactor Expression. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 23:219-226.
  45. Lin JJ; Kim JH. Retrovirus-Mediated Gene Transduction of SupT1 Cells. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 24:227-236.
  46. Krider M; Loomis-Price LD. Serologic Analysis by Enzyme-Linked Immunosorbent Assay (ELISA). In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 27:245-254.
  47. Mitchell MM; Loomis-Price LD. Quantitative Immunoblotting with Fusion Proteins. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 28:255-264.
  48. VanCott TC; Halberg PL. Analysis of Antibody Interactions with HIV-1 Envelope Expressed on the Surface of Acutely Infected H9 Cells. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 29:265-272.
  49. VanCott TC. Analysis of Antibody-Antigen Interactions Using Surface Plasmon Resonance. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 30:273-282.
  50. Van Ginkel FW; VanCott JL; Kaminski R;VanCott TC. Measurement of HIV-1 Specific and Total Antibody Secreting Cells by ELISPOT. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 31:283-292.
  51. Loomis-Price LD. Linear Epitope Mapping by the PEPSCAN Method. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 32:293-308.
  52. Mascola JR. Neutralization of HIV-1 Infection of Human Perioheral Blood Mononuclear Cells (PBMC): Antibody Dilution Method. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 33:309-316.
  53. Masccola JR. Neutralization of HIV-1 Infection of Human Peripheral Blood Mononuclear Cells (PBMC): Inffectivity Reduction Method. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 34:317-322.
  54. Artenstein AW; VanCott TC. Collection and Processing of Mucosal Secretions from HIV-1 Infected Women. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 35:323-328.
  55. Kaminski RW; VanCott TC. Collection and Processing Mucosal Secretions from Mice. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 36:329-342.
  56. Sitz KV; Birx DL. Lymphocyte Proliferation Assay. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 37:343-354.
  57. Cox JH. HIV-1 Specific Cytotoxic T-Cell Assays. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 38:355-372.
  58. Cox JH. HIV-1 Specific Antibody-Dependent Cellular Cytotoxicity (ADCC). In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 39:373-382.
  59. Cox JH. Evaluation of Natural Killer Cell Activity. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 40:383-390.
  60. Ratto-Kim S. Generation and Expansion of HIV-1 CD4+ Antigen Specific T Cell Lines. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 41:391-396.
  61. Perfetto SP; McCrary G. Immunophenotyping and Assessment of Cell Function by Three-Color Flow Cytometry of Peripheral Blood Lymphocytes. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 42:397-406.
  62. Blair PJ; Perfetto SP. Detection of Apoptosisin HIV-Infected Cell Populations Using TUNEL. In: Michael NL; Kim JH eds. Methods in Molecular Medicine, HIV Protocols. Totowa; New Jersey: Humana Press, 1999: Chapter 43:407-412
  63. Gulgolgarn, V., Ketsararat, V., Niyomthai, R., Junsiriyotin, K., Thungjang, S., Leelaporn, W., Tovanabutra, S., Nelson, K., Khamboonrueng, C. and Robb, M., Somatic growth and clinical manifestation in formula fed infants born to HIV--infected mothers during the first year of life. J Med Assoc Thai 1999. 82: p1094-1099.
  64. Janoff, E., Tasker, S., Stevenson, M., Rubins, J., O'Brien, J., Utz, G., Weiss, P., Hall, F. and Wallace, M., Immune activation and virologic response to immunization in recent HIV type 1 seroconverters. AIDS Res Hum Retroviruses 1999. 15: p837-845
  65. Laukkanen, T., Albert, J., Liitsola, K., Green, S., Carr, J., Leitner, T., McCutchan, F. and Salminen, M., Virtually full-length sequences of HIV type 1 subtype J reference strains. AIDS Res Hum Retroviruses 1999. 15: p293-297
  66. Mariani, R., Wong, S., Mulder, L., Wilkinson, D., Reinhart, A., La, R. G., Nibbs, R., O'Brien, T., Michael, N., Connor, R., Macdonald, M., Busch, M., Koup, R. and Landau, N., CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function. J Virol 1999. 73: p2450-2459
  67. Oelrichs, R., Vandamme, A., Van, L. K., Debyser, Z., McCutchan, F. and Deacon, N., Full-length genomic sequence of an HIV type 1 subtype G from Kinshasa. AIDS Res Hum Retroviruses 1999. 15: p585-589
  68. Tasker, S., Treanor, J., Paxton, W. and Wallace, M., Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999. 131: p430-433
  69. Thapinta, D., Jenkins, R., Celentano, D., Nitayaphan, S., Buapunth, P., Triampon, A., Morgan, P., Khamboonruang, C., Suwanarach, C., Yutabootr, Y., Ruckphaopunt, S., Suwankiti, S., Tubtong, V., Cheewawat, W., McNeil, J. and Michael, R., Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers. J Acquir Immune Defic Syndr Hum Retrovirol 1999. 20: p308-314
  70. Williams, S., Flanigan, T., Artenstein, A., Van, C. T., Smith, D., Mayer, K. and Koup, R., CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection. J Infect Dis 1999. 179: p1310-1312
  71. Vahey, M., M. Nau, S. Barrick, J. Cooley, P. Vickerman, B. Larder, N. Michael and S. Wegner. 1999. Evaluation of the Affymetrix GeneChip HIV PRT 440 Platform For Antiretroviral Drug Resistance Genotyping of Diverse HIV-1 Clades and Viral Isolates with Length Polymorphisms. J. Clin Microbiol. 37:2533-2537.
  72. Robertson DL, Anderson JP, Bradac J, Carr JK, Foley B, Gao F, Hahn BH, Kuiken C, Learn GH, Leitner T, McCutchan F, Mullins JI, Osmanov S, Peeters M, Pienizaek D, Rodrigo A, Salminen M, Wolinsky S, Korber B. 1999. HIV Nomenclature Proposal. In: Human retroviruses and AIDS, Los Alamos National Laboratory, Los Alamos, NM.